TrialDiabetes, obesity & metabolism2014

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.

J P H Wilding et al.PubMed ↗Publisher ↗

No numbers read from the abstract.